Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribonucleotide reductase large subunit, also known as RRM1, is a critical enzyme in DNA synthesis and cellular metabolism. It catalyzes the biosynthesis of deoxyribonucleotides from corresponding ribonucleotides, providing the necessary precursors for DNA replication during the S phase of the cell cycle. RRM1 is a target for the chemotherapeutic agent gemcitabine and has been extensively studied as a potential biomarker in various cancer types.
RRM1 serves as a cellular target for the chemotherapeutic agent gemcitabine
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribonucleotide Reductase Large Subunit (RRM1).